[1] | Jianxing LUO, Yang ZHANG, Ne XIANG, Xiaoyu HU. Efficacy and safety of microwave ablation versus hepatic resection in treatment of hepatocellular carcinoma with liver cirrhosis: A Meta-analysis[J]. Journal of Clinical Hepatology, 2024, 40(9): 1807-1815. doi: 10.12449/JCH240915 |
[2] | Zhangpeng WANG, Guangxu JING, Huanhuan LUO, Hongfei DONG, Xuyang WANG, Hongyu SUN, Lijun TANG. Efficacy and safety of aggressive fluid resuscitation versus conventional fluid resuscitation in early treatment of acute pancreatitis: A Meta-analysis[J]. Journal of Clinical Hepatology, 2023, 39(9): 2158-2168. doi: 10.3969/j.issn.1001-5256.2023.09.019 |
[3] | Yin WeiLi, Lian Jia, Xiao ShiXiang, Xiang HuiLing, Liu Ying, Qian BaoXin, Wang Tao, Li Ying, Jin YuXia, Han Tao. Clinical effect of drug-eluting beads and conventional transcatheter arterial chemoembolization in treatment of unresectable liver cancer: A meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(6): 1270-1275. doi: 10.3969/j.issn.1001-5256.2019.06.018 |
[4] | Li Jing, Jiang Yong, Zhang Xu. Efficacy of transjugular intrahepatic portosystemic shunt versus endoscopic cyanoacrylate injection in treatment of gastric variceal bleeding: A meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(2): 349-353. doi: 10.3969/j.issn.1001-5256.2019.02.021 |
[5] | Li Min, Dan Shan, Wu XiaoNing, Kong YuanYuan, Ou XiaoJuan, You Hong, Jia JiDong. Clinical effect of interferon in treatment of genotype B or C chronic hepatitis B patients: A meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(6): 1256-1261. doi: 10.3969/j.issn.1001-5256.2019.06.015 |
[6] | Shi Ke, Wang XiaoJing, Wang XianBo. Clinical effect of Jinlong capsules combined with Western medicine treatment in treatment of primary liver cancer:A Meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(11): 2495-2501. doi: 10.3969/j.issn.1001-5256.2019.11.021 |
[7] | Yu JiShang, Wu Fan, Tan GuoQian, Wang BaiLin. Clinical effect of mesohepatectomy versus hemihepatectomy in treatment of centrally located hepatocellular carcinoma: A Meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(5): 1008-1013. doi: 10.3969/j.issn.1001-5256.2019.05.015 |
[8] | Sun YuanPei, Guo XiaoXia. Clinical effect of probiotics in treatment of liver cirrhosis: a Meta-analysis[J]. Journal of Clinical Hepatology, 2018, 34(1): 73-79. doi: 10.3969/j.issn.1001-5256.2018.01.015 |
[9] | Yan JinZhu, Weng Hong, Zhang Chao, Wang Yuan, Yang Jian, Peng XinYu. Clinical effect and safety of percutaneous radiofrequency ablation versus microwave ablation in treatment of hepatocellular carcinoma:a Meta-analysis[J]. Journal of Clinical Hepatology, 2018, 34(5): 1025-1032. doi: 10.3969/j.issn.1001-5256.2018.05.020 |
[10] | Hou Jie, Liu LiXin. Effect of probiotics in treatment of nonalcoholic fatty liver disease: A Meta-analysis[J]. Journal of Clinical Hepatology, 2018, 34(12): 2624-2630. doi: 10.3969/j.issn.1001-5256.2018.12.023 |
[11] | Mao HaiYing, Kang Tao, Yao Ling, Chen Qin. Efficacy of glycyrrhizin in patients with chronic severe hepatitis B:a meta-analysis[J]. Journal of Clinical Hepatology, 2015, 31(1): 63-67. doi: 10.3969/j.issn.1001-5256.2015.01.014 |
[12] | Zhang WenWen, Qi XingShun, Guo XiaoZhong. Mirabilite umbilical compress in treatment of ascites in liver cirrhosis: a meta-analysis[J]. Journal of Clinical Hepatology, 2015, 31(6): 947-950. doi: 10.3969/j.issn.1001-5256.2015.06.028 |
[13] | Yu Yuan, Yang ZongGuo, Chen ChiChi, Lu YunFei, Xu QingNian, Chen XiaoRong. Efficacy of adjuvant therapy with fenofibrate for primary biliary cirrhosis: a Meta-analysis[J]. Journal of Clinical Hepatology, 2015, 31(10): 1630-1633. doi: 10.3969/j.issn.1001-5256.2015.10.017 |
[14] | Zhou LiJun. Clinical efficacy of Liuweiwuling tablets in treatment of non- alcoholic fatty liver disease: a meta- analysis[J]. Journal of Clinical Hepatology, 2015, 31(7): 1068-1072. doi: 10.3969/j.issn.1001-5256.2015.07.017 |
[15] | Zhang YuHuai, Luo ZhangJiang. Efficacy and safety of octreotide in treatment of hepatocellular carcinoma: a meta-analysis[J]. Journal of Clinical Hepatology, 2015, 31(6): 922-926. doi: 10.3969/j.issn.1001-5256.2015.06.023 |
[16] | Wu JiYuan, Zhang DongQin, Zhang HaiYue, Wang LuWen, Gong ZuoJiong. Efficacy and safety of transjugular intrahepatic portosystemic shunt versus endoscopic therapy for prevention of variceal rebleeding in patients with cirrhosis: a meta-analysis[J]. Journal of Clinical Hepatology, 2014, 30(12): 1272-1278. doi: 10.3969/j.issn.1001-5256.2014.12.010 |
[17] | Chen XiaoHong, Wu ZongYing, Wang YiPing, Ceng Chao, Pan Tao. Fatality and adverse event rates of prostaglandin E in treating acute liver failure: a meta- analysis[J]. Journal of Clinical Hepatology, 2013, 29(9): 681-684. doi: 10.3969/j.issn.1001-5256.2013.09.012 |
[18] | Yang Jun, Meng QingHua, Yu HongWei. Sorafenib combined with thanscatheter artierial chemoembolzation in treatment of advanced hepatocellular carcinoma: Meta analysis[J]. Journal of Clinical Hepatology, 2013, 29(10): 764-768. doi: 10.3969/j.issn.1001-5256.2013.10.011 |
[19] | Ye Gang, Ma Yu, Tang ChengJia, Du ChengYou. Clinical outcomes of laparoscopic hepatectomy and open hepatectomy for hepatocellular carcinoma: A meta-analysis[J]. Journal of Clinical Hepatology, 2013, 29(3): 184-190. |
[20] | Song LiWen, Zhao GuiMing, Cao WuKui, Lu ChengZhen. Meta analysis of the comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(9): 955-961. |